Jim Faulkner, PhD.

Scientific Advisor

Jim is a highly experienced biopharmaceutical development leader with specialist skills in gene and cell therapy. Recognized for taking more than 25 different medicines into the clinic, including multiple CAR-T assets, Jim currently serves as Chief Technology Officer at Ascidian Therapeutics and was SVP, Product Delivery for Autolus Ltd, a clinical-stage CAR-T company spun out of University College London. Responsible for process development, technical operations, engineering and supply chain, Jim served on the leadership team that took Autolus from start-up to successful IPO in three years.